ARCHIVES

Nexavar Phase III Trial Fails To Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

NIH Workshop On Animal Care Planned

May 4, 1990

FDA Oncology Division To Develop Papers On Expectations for New Drugs

August 2, 1996

DRCCA Board Approves CCOP, Limited Recompetition Of Cooperative Group Program, New Control Efforts

October 30, 1981

Greenberg: More Work Needs to be Done

November 7, 2014

NCI Awards 12 Grants For Planning of New Cancer Centers

March 27, 1992

Anticancer Vaccine Trials Due In Three-Four Years; Virus Research Opportunities Described

July 25, 1975